We are live on ! Find out more
CRB

Chad R. Baker Portfolio holdings

AUM $620M Turnover 12.28%
1-Year Est. Return 42.67%
This Fund
S&P 500
This Quarter Est. Return
+12.21%
1 Year Est. Return
+42.67%
3 Year Est. Return
+108.31%
5 Year Est. Return
+132.08%
10 Year Est. Return
+563.15%
AUM
$483M
AUM Growth
+$37.3M
Cap. Flow
-$6.9M
Cap. Flow %
-1.43%
Top 10 Hldgs %
44.28%
Holding
54
New
2
Increased
–
Reduced
4
Closed
4
Avg Time Held
4.5 years
Top 10 Avg Time Held
2.3 years
Top 20 Avg Time Held
3.5 years

Top Buys

Rank Stock Value
1
BEAM icon
Beam Therapeutics
BEAM
+$2.36M
2
PACB icon
Pacific Biosciences
PACB
+$2M

Top Sells

Rank Stock Value
1
TDOC icon
Teladoc Health
TDOC
+$3.23M
2
FISV icon
Fiserv Inc
FISV
+$2.6M
3
BDX icon
Becton Dickinson
BDX
+$2.46M
4
AAPL icon
Apple
AAPL
+$1.36M
5
RTX icon
RTX Corp
RTX
+$727K

Sector Composition

Rank Sector Weight
1 Technology 26.02%
2 Healthcare 20.2%
3 Industrials 16.73%
4 Consumer Discretionary 13.43%
5 Communication Services 11.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
BDX icon
51
Becton Dickinson
BDX
$52.2B
– –
-10,250
Closed -$2.46M –
FISV icon
52
Fiserv Inc
FISV
$25.3B
– –
-24,000
Closed -$2.6M –
TDOC icon
53
Teladoc Health
TDOC
$1.03B
– –
-25,470
Closed -$3.23M –
VNT icon
54
Vontier
VNT
$4.51B
– –
-6,000
Closed -$202K –

Similar funds

Chad R. Baker's Q4 2021 Portfolio in Review

As of Q4 2021, Chad R. Baker held 54 positions worth $483M, up 8.4% from $446M the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Chad R. Baker's Q4 2021 filing shows 2 new, 4 reduced and 4 closed positions. Its largest new stake was Beam Therapeutics: 27,550 shares worth $2.19M. The largest sale was Teladoc Health, an estimated $3.23M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 24% a quarter earlier, followed by Healthcare and Industrials.

  • Chad R. Baker's largest Q4 2021 buy was Beam Therapeutics: 27,550 shares worth $2.19M.
  • Chad R. Baker's biggest Q4 2021 reduction was Apple, cutting an estimated $1.36M.
  • Chad R. Baker fully exited Teladoc Health in Q4 2021, selling an estimated $3.23M.
  • Chad R. Baker's ten largest holdings make up 44% of its $483M portfolio in Q4 2021.
  • Chad R. Baker opened 2 new positions and closed 4 in Q4 2021.
  • Chad R. Baker's portfolio value rose 8.4% quarter-over-quarter to $483M.

Based on Chad R. Baker's 13F filing for Q4 2021, filed 8 Feb 2022.